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Abstract
Background: Gene copy number variants (CNVs), which consist of deletions and amplifications of single or sets of
contiguous genes, contribute to the great diversity in the Plasmodium falciparum genome. In vitro studies in the
laboratory have revealed their important role in parasite fitness phenotypes such as red cell invasion, transmissibility
and cytoadherence. Studies of natural parasite populations indicate that CNVs are also common in the field and
thus may facilitate adaptation of the parasite to its local environment.
Results: In a survey of 183 fresh field isolates from three populations in Eastern Africa with different malaria
transmission intensities, we identified 94 CNV loci using microarrays. All CNVs had low population frequencies
(minor allele frequency < 5%) but each parasite isolate carried an average of 8 CNVs. Nine CNVs showed high
levels of population differentiation (FST > 0.3) and nine exhibited significant clines in population frequency
across a gradient in transmission intensity. The clearest example of this was a large deletion on chromosome
9 previously reported only in laboratory-adapted isolates. This deletion was present in 33% of isolates from a
population with low and highly seasonal malaria transmission, and in < 9% of isolates from populations with
higher transmission. Subsets of CNVs were strongly correlated in their population frequencies, implying
co-selection.
Conclusions: These results support the hypothesis that CNVs are the target of selection in natural
populations of P. falciparum. Their environment-specific patterns observed here imply an important role for
them in conferring adaptability to the parasite thus enabling it to persist in its highly diverse ecological
environment.
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Background
P. falciparum, the most virulent of the species that cause
malaria in humans, is characterized by extensive genetic
diversity that enables the parasite to escape host im-
mune defence, resist antimalarial drugs and pose a fur-
ther challenge to vaccine development [1–4]. Sources of
genomic variation in this parasite range from changes at
the single nucleotide level through to large structural al-
terations of the chromosomes. Gene copy number vari-
ants (CNVs) lie between these extremes, consisting of
deletions and amplifications of a gene or set of contigu-
ous genes. CNVs are thought to directly affect the level
of gene expression through altering gene dosage, but
also indirectly through modification of the chromatin
environment in the vicinity of the CNV (reviewed in
[5]). Potentially, therefore, CNVs may influence clinically
relevant parasite phenotypes such as drug resistance,
erythrocyte invasion and transmissibility.
Interest in CNVs in malaria parasites has been driven
by confirmation of their role in adaptation, evolution
and disease in other organisms [6–9], boosted by ad-
vances in technologies for high-throughput genome-
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wide scans of the malaria genome [10]. Surveys of para-
site lines adapted to in vitro culture conditions in the la-
boratory, both long-term [11–17] and short-term [18],
have revealed many CNVs in the P. falciparum genome.
Common among these are two large deletions that abro-
gate traits which are crucial to survival in vivo but dis-
pensable in vitro. These are the deletion of a region on
chromosome 9 that contains several genes required for
formation of gametocytes, the life stage required for
transmission to new hosts via mosquitoes [19, 20], and a
region on chromosome 2 containing a gene encoding
the knob associated histidine rich protein (KAHRP) that
mediates binding of the infected red blood cell to other
host cells (cytoadherence) thereby allowing the parasite
to avoid circulation through the spleen where it would
otherwise be destroyed [21]. Another example of an in
vitro-associated CNV is the amplification of
reticulocyte-binding protein 1 encoding gene (rh1) [12,
16, 18, 22]. This protein is involved in red cell invasion
[23] and appears to be associated with increased parasite
asexual replication rate in vitro [16, 22]. In vitro selec-
tion for drug resistance has uncovered further CNVs.
Examples include amplification of genes encoding multi-
drug resistance protein 1 (Pfmdr1) that associates with
resistance to multiple drugs in in vitro studies [24]; am-
plifications in the genes encoding the cysteine proteases
falcipain 2 (FP2a and FP2b) and falcipain 3 (FP3) in
which mutations have been associated with resistance to
the antimalarial compound artemisinin [25], and which
help breakdown haemoglobin in the food vacuole [26], a
process that is required for artemisinin to be effective
[27]; a deletion of 15 consecutive genes on chromosome
10 in parasites bearing mutations in the chloroquine re-
sistance transporter gene (Pfcrt) [28]; deletion of 23 adja-
cent genes in chromosome 14 in strains resistant to the
anti-malarial compound, fosmidomycin [13]; and ampli-
fication of the gene encoding GTP cyclohydrolase 1
(gch1) [12, 18], an enzyme high in the folate synthesis
pathway and thus a potential target for the antifolate
class of anti-malarial drugs. Most of these laboratory-
derived CNVs have been shown to affect expression
levels of genes inside the CNV and, in a few cases, genes
located on other chromosomes [18, 28]. Combined, the
evidence from in vitro studies strongly supports the hy-
pothesis that CNVs play an important role in parasite
adaptation to novel environments.
The relevance of in vitro-based studies of CNVs to
parasite adaptation in the field remains unclear, however.
For example, the cytoadherence and gametocyte-linked
deletions on chromosome 2 and 9, and the replication-
linked rh1 amplification have not been found among the
limited number of field isolates of P. falciparum sur-
veyed to date [22, 29]. This implies strong selection
against these mutations in vivo. On the other hand,
CNVs involving drug resistance have been observed in
the field, e.g., amplifications in mdr1 in patients with
failed response to drugs [30], and gch1 amplification in
populations subjected to antifolate drug pressure [31,
32], thus reflecting their adaptive value under field con-
ditions if there are novel selection forces at play. Many
CNVs not observed among laboratory isolates and of un-
known clinical or adaptive significance have been discov-
ered in global surveys of field populations [29]. Indeed,
it is estimated that between 0.3 - 6% of the parasite’s
genome is subject to variation in gene copy number.
This is greater than the fraction represented by single
nucleotide polymorphisms (SNPs).
Thus the evidence to date suggests that CNVs play
a significant role in adaptation of the parasite to
novel environmental conditions. Whether this in-
cludes naturally varying factors such as immunity,
mosquito density and host genetics, as distinct from
selective agents not previously encountered such as
drugs, remains unknown. Here, we test the hypothesis
that CNVs provide the source of adaptive variation
used by the parasite to evolve in response to natural
environmental variation. Empirical support for this
hypothesis would have implications for malaria con-
trol programmes that change the epidemiological set-
ting of the parasite. We examine this hypothesis by
analysing CNV variation among geographically and
temporally separated populations of P. falciparum in
Eastern Africa that differ widely in malaria transmis-
sion intensity and thus related selection pressures.
We further test for experimental sources of variation
in the detectability of CNVs in order to account for
or rule out experimental bias in our results.
Results and discussion
General properties of CNVs
From 183 P. falciparum infected blood samples
(Table 1), using a microarray previously validated for
CNV detection [18] and after applying stringent CNV
definition criteria, a total of 94 different CNVs with
minor allele frequency (MAF) greater than 2.2% (i.e.,
found in 4 or more samples), and containing 228
different genes, were detected (Additional file 1).
Thirty-one of these were classed as deletions, 58 as
amplifications and 5 as carrying both types of alleles
(“amp-dels”). These classifications were made in refer-
ence to the P4 isolate [18] with one exception,
namely, cnv9_269 for which P4 carried a deletion: in
this case, the deletion was defined with respect to the
majority of isolates in the sample population.
CNVs were distributed throughout the 14 chromo-
somes of the parasite’s nuclear genome (Fig. 1a).
CNVs varied in size from 400 bp to 90 kb (Fig. 1b).
The majority of CNVs contained less than 3 genes
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Table 1 Characteristics of the four study populations
Population Kisumu Kilifi pre malaria decline Kilifi post malaria decline Sudan
Malaria transmission intensity High Medium-high Medium-low Low
Number of samples 49 33 49 52
Year of sample collection 2008 1994–1996 2010 2007
Median age in months 36 30 53.5 84
(range) (6–72) (11–37) (14–147) (12–612)
log10 median parasitaemia 5.3 4.7 5.1 5.1
(par/μl) (range) (4.9–5.8) (4.0–5.8) (2.5–6.1) (4.4–5.8)
Median hemoglobin (g/dl) 9.9 9.4 10.6 9.6
(range) (5.2–15.2) (5.3–13.2) (3.4–12.1) (3.2–12.9)
Median number of clones 2 2 2 2
(range) (1–6) (1–7) (1–5) (1–5)
Monoclonal infections
(percentage)
10.2 33.3 18.4 26.9
Fig. 1 Location and properties of CNVs in the P. falciparum genome. a Chromosomal location of the 94 CNVs in the 14 nuclear chromosomes of the
P. falciparum genome (deletions in blue and amplifications in red). White vertical bars represent regions not targeted by the microarray probes. Black
vertical bars are locations of centromeres. Distributions of length of CNVs (b), number of genes per CNV (c) and number of CNVs per sample (d) split
by study population (horizontal line, median number; top and bottom boundaries, 75th and 25th percentiles; whiskers, minimum and maximum)
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(median of 2) with the largest CNV on chromosome
9 consisting of 18 genes (Fig. 1c). The number of
CNVs per sample ranged from 0 to 19 with an aver-
age of 8 CNVs per isolate (Fig. 1d) The summed
length of all CNVs identified here was 786.7kbp
which represents 3.4% of the parasite genome and ap-
proximately 4.5% of genes in the genome. Twenty of
the 94 CNVs detected here (21%) have been reported
in previous studies (Additional file 1), albeit with dif-
ferent breakpoints in some cases: thus the majority of
CNVs identified here are novel. Nonetheless, these re-
sults accord with previous studies showing consider-
able amounts of standing variation in CNV loci in
field populations [16, 29] and thus support the hy-
pothesis that CNVs play an adaptive role in natural
populations of P. falciparum.
Systematic effects on general CNV prevalence
Most CNVs had low population frequencies (< 5%, Fig. 2).
There were no significant effects of multiplicity of infec-
tion (MOI), parasitaemia and patient characteristics (age
and haemoglobin), or two-way interactions between these
factors, on the population prevalence of CNVs overall
(P > 0.05 by F-test, Fig. 2a). This rules out possible bias in
detectability of CNVs due to ‘dilution’ in the case of MOI,
and total DNA concentration effects in the case of parasit-
aemia. By contrast, study population was a strong deter-
minant of overall CNV prevalence (P < 0.001), with overall
lower prevalence in the medium transmission populations
(Kilifi) than in the high and low transmission populations
(P = 0.35 fitting a linear covariate for transmission inten-
sity, Fig. 2a). Thus population differences in CNV preva-
lence were not due to bias in detectability caused by
sample processing or infection and host-related factors.
Properties of the genes contained within the CNVs
and their encoded proteins did not, in general, relate to
the probability of being copy number variable. Excep-
tions to this were as follows: amplification CNVs were
more likely to occur in genes that had maximum expres-
sion levels during the rings and trophozoite stages
within the 48 h replication cycle (P = 0.02 by likelihood
ratio test, Fig. 2b); deletion CNVs were more prevalent
in genes with high asexual:sexual stage expression ratios
(P = 0.02, Fig. 2c); and there was a significant, but not
unidirectional, effect of SNP density on the prevalence
of deletion CNVs (P = 0.02).
Seven of 255 functional categories of genes were
highly significantly enriched for genes belonging to
CNVs, five of them for deletion CNVs (nominal P < 0.01
by hypergeometric test, only two of which were signifi-
cant (P < 0.05) after accounting for multiple testing
(Table 2). Enriched pathways included those involved in
export of proteins to the surface of infected red blood
cells, and in core metabolic processes such as glycolysis,
intracellular trafficking and transcriptional regulation
(Table 2). These results indicate that CNVs are not con-
fined to non-essential, non-central processes, as might be
expected if the alterations in gene copy number led to dra-
matic, irreversible changes to gene expression levels.
Evidence of population-specific adaptation
Many CNVs (28 of 99 when defining amp-dels as two sep-
arate CNVs) were present in all four populations and a
few (12/99) were exclusive to single populations (Fig. 3a).
Mean FST values ranged between 0.02 and 0.11 across the
6 pairwise population comparisons (Fig. 3c) which are typ-
ical values of background population differentiation in P.
falciparum based on SNPs [33]. However, nine CNVs (9%)
had pairwise FST values greater than the arbitrary signifi-
cance threshold of 0.3, equivalent to the top 3% of all
population pairwise values (Fig. 3c). These were thus de-
clared as potential targets of population-specific selection
(Table 3).
A higher than expected number of CNVs showed sig-
nificant transmission intensity-related clines in population
frequency (P < 0.001 based on the distribution of the glo-
bal test statistic from permuted data, Table 3, Fig. 3b).
Nine CNVs (9%, 4 amplifications and 5 deletions) showed
individual significance after adjustment for multiple test-
ing (Benjamini-Hochberg adjusted P < 0.05). All of these
CNVs decreased in frequency as transmission intensity in-
creased (Table 3). One of these was the large deletion on
the right arm of chromosome 9 (cnv9_269) that has previ-
ously been observed only in laboratory-adapted isolates
[11, 12, 16, 18, 19, 34]. A further seven CNVs (6 with
negative clines, 2 of which were deletions) had marginally
significant frequency clines (adjusted P < 0.10). There was
strong overlap in the CNVs displaying population differen-
tiation by FST and those exhibiting transmission-related
clines (Table 3).
These results strengthen the argument that CNVs play a
role in local adaptation of P. falciparum to its natural envir-
onment. Our results suggest that a ‘landscape genomics’
approach applied to malaria parasite populations on a
much larger scale than in this study might accelerate
progress towards identification of genetic variants that en-
able the parasite to survive and thrive in its highly variable
environment. Such an approach has been demonstrated as
successful in identifying adaptive genes in humans affecting
metabolic disease due to diet, altitude and heat [35, 36] and
infectious diseases such as malaria [37].
The chromosome 9 deletion
The most striking transmission-related frequency cline
was in cnv9_269 which was found most often in Sudan
(17 out of 52 isolates, 33%), but at low frequency in
other populations (< 9%). Its reported absence from
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isolates taken directly from patients in previous studies
has led to the interpretation that this deletion is an arte-
fact of in vitro culture, assumed to arise from a replica-
tion advantage under these novel conditions, but
strongly selected against in nature because it contains
genes coding for several proteins essential for early
gametocyte development [38, 39] and thus transmission.
The deleted region also contains genes encoding proteins
Fig. 2 Systematic effects of host, parasite and gene factors on overall CNV prevalence. a Effects of host status, infection status and population on
population prevalence of all CNVs. b Effects of gene properties on genomic prevalence of amplification CNVs. c As for b but for deletion CNVs.
Points show least-squares means for each level of the factors (x-axis) adjusted for other factors in the model (separate panels). Vertical lines show
upper and lower 95% confidence intervals. Significance of each factor is indicated at the top of each panel. *, P < 0.05; ***, P < 0.001
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Table 2 Functional gene categories showing significant enrichment for CNVs
Functional gene set No. of genes
in CNVs





Exported proteins - PHISTs 8 48 < 0.001 < 0.001
Characteristics of Plasmodium falciparum
export proteins that remodel infected
erythrocyte
5 35 < 0.001 0.043
Glycolysis 4 27 0.001 0.10
Exported proteins - Unique 6 72 0.0025 0.10
Utilization of phospholipids 4 40 0.005 0.26
Amplifications
Rab and other proteins involved in
intracellular traffic
3 14 0.009 1
RNA binding genes 12 173 0.01 1
aBy hypergeometric test without adjustment for testing of multiple gene sets
bAdjusted for multiple-testing by the Benjamini-Hochberg method
Fig. 3 Population differentiation of CNVs. a Overlap of CNVs between populations. b Distribution of transmission intensity-related frequency clines
(z-score) among the CNVs (filled bars, red for amplifications, green for deletions) vs. the expected distribution based on permuted data (black line).
Vertical solid lines indicate the upper and lower 2.5% probability thresholds of the latter. Vertical dashed lines indicate the equivalent thresholds
after Benjamini-Hochberg adjustment for multiple testing. c Distributions of population pairwise FST estimates for CNVs (dots, individual CNVs;
horizontal line, median number; top and bottom boundaries, 75th and 25th percentiles, whiskers, minimum and maximum)
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Table 3 CNVs showing evidence of population-specific adaptation. Only those CNVs that either had FST greater than 0.30 or which
showed significant transmission intensity-related clines in population frequency are shown
CNV name CNV type FST
a Clineb Annotationsc
cnv5_101 Amplification 0.64 - *** 6-cysteine protein (P38) SET domain protein, putative (SET9)
cnv12_413 Amplification 0.64 -*
cnv9_242 Amplification 0.44 P1 nuclease, putative
cnv13_478 Deletion 0.46 - † E1-E2 ATPase, putative
cnv9_254 Deletion 0.41 protein phosphatase-beta thioredoxin-like protein 2 (TLP2) zinc
binding protein (Yippee), putative histone deacetylase 1 (HDAC1)
cnv3_051 Amplification 0.34 circumsporozoite- and TRAP-related protein (CTRP)
cnv3_036 Amplification 0.32 -† Plasmodium exported protein (hyp1), unknown function (GEXP21)
Plasmodium exported protein, unknown function
Plasmodium exported protein, unknown function
cnv6_129 Deletion 0.30 ubiquitin-conjugating enzyme E2, putative polypyrimidine tract binding
protein, putative
cnv4_078 Amplification 0.30 -†
cnv11_354 Deletion 0.27 Plasmodium exported protein (PHISTc), unknown function (GEXP12)
Plasmodium exported protein (hyp11), unknown function
Plasmodium exported protein, unknown function
cnv11_355 Deletion 0.18 -*** antigen 332, DBL-like protein (Pf332)
cnv9_269 Deletion 0.27 -*** gametocyte development protein 1 (GDV1)
Plasmodium exported protein, unknown function (GEXP22)
gametocytogenesis-implicated protein (GIG)
Plasmodium exported protein, unknown function
cytoadherence linked asexual protein 9 (CLAG9)
ring-exported protein 1 (REX1)
ring-exported protein 2 (REX2)
early transcribed membrane protein (ETRAMP9)
ring-exported protein 4 (REX4)
virulence-associated protein 1 (VAP1)
Plasmodium exported protein (PHISTc), unknown function
(GEXP05)
lysophospholipase, putative
Plasmodium exported protein (PHISTc), unknown function
Plasmodium exported protein (PHISTb), unknown function
Plasmodium exported protein, unknown function
lysophospholipase, putative
cnv1_007 Amplification 0.26 -** tubulin-specific chaperone a, putative N-acetyltransferase, putative
cnv14_549 Amplification 0.21 -*** thioredoxin peroxidase 1 (Trx-Px1) copper transporter
cnv11_355 Deletion 0.18 - *** antigen 332-DBL-like protein (Pf332)
cnv2_023 Deletion 0.14 -* conserved Plasmodium membrane protein, unknown function
cnv12_368 Deletion 0.07 -* glycerol-3-phosphate dehydrogenase, putative
aMaximum of pairwise population FST values
bSignificance of transmission intensity cline in CNV frequency after Benjamini-Hochberg correction for multiple testing. (†, P < 0.10;*, P < 0.05;**, P < 0.01;***, P <
0.001; +, positive association; −, negative association). Four further CNVs had clines with adjusted P < 0.10 but FST < 0.3 and so are not shown (three amplifications,
cnv9_262, − †; cnv5_109, + †; cnv14_573, − †, and one deletion, cnv7_193, − †)
cExcluding genes with no known or putative function
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involved in cytoadherence [40], the in vivo process by
which parasite-infected red cells adhere to vascular
tissues and thereby protect parasite infected red cells
from being circulated and destroyed by the spleen.
Since cytoadherence is redundant in vitro, selection
against this deletion would only be expected to occur
in vivo, just as for gametocyte development genes. A
replication advantage of this deletion in vitro might
arise from the lower metabolic cost of DNA replica-
tion of a smaller genome. Alternatively, it may arise
because the production of gametocytes imposes a cost
on asexual replication [41]. These advantages would
also be expected to apply in vivo.
We envisage two possible mechanisms for how this
deletion could be maintained in natural populations des-
pite its apparent cost to transmission and survival of
host clearance mechanisms, and for why these may be
more powerful in areas with low or strongly seasonal
transmission intensities. First, the mutation may com-
monly arise de novo in new infections, rising to high
within-host frequency due to a replication advantage,
but ultimately being unable to transmit. Such ‘short-
sighted, dead-end’ within-host evolution has been in-
voked to explain the high virulence of some pathogens
[42]. In Plasmodium, such a scenario would be favoured
when there are long mosquito-free periods between mal-
aria transmission seasons, as occur in the eastern Sudan
population examined here, because there is no transmis-
sion cost to counteract the short-term selection for rapid
replication.
An alternative explanation is that genomes with inher-
ent instability at the chromosome 9 locus are maintained
in natural parasite populations through ‘bet hedging’.
Under this scenario, within a host, a subset of asexual
lineages deriving from the same parasite clone may carry
the deletion while simultaneously maintaining intact lin-
eages that are capable of transmitting. A bet-hedging
strategy would be selectively favoured when there is no
competition from co-infecting genotypes for uptake by
the mosquito. It would also require that kin selection
was at play, as appears to be the case for sex ratio ad-
justment by Plasmodium in response to the presence of
unrelated genotypes [43].
Both these explanations are consistent with the high
frequency of cnv9_269 in the highly seasonal setting of
Sudan observed here. This observation also accords with
the finding in two populations in west Africa of extreme
FST values for five SNPs within and adjacent to the first
gene in cnv9_269 (gdv1, encoding gametocyte develop-
ment protein1, PF3D7_0935400). In this case, the minor
allele was found more often in the population with
strong malaria seasonality than in the population with
year-round transmission [44], consistent with this study.
Thus there is mounting evidence that this locus is the
target of selection in highly seasonal and low transmis-
sion environments.
It seems likely that the cnv9_269 deletion has escaped
detection in field isolates until now because for most de-
tection methods, including CGH, its presence would be
masked by non-deleted genomes in the parasite popula-
tion in the blood. This masking effect would be stron-
gest in high transmission areas where most infections
are multi-clonal, and thus may have contributed to the
observed negative frequency cline in cnv9_269 and other
deletions found in this study.
Associations between CNVs
Linkage disequilibrium analyses revealed three distinct
sets of CNVs (Blocks 1 to 3) with strong population-
level associations between them (0.6 < r < − 0.4) (Fig. 4a).
The largest block (Block 3) contained approximately
equal numbers of amplification and deletion CNVs
which, respectively, typically contained genes with high
and low sexual stage expression levels (Fig. 4b), and thus
are denoted as ‘sexual stage CNVs’ here. There was a
striking negative correlation between Block 3 CNVs and a
deletion CNV that was not a member of any block, cnv9_
254. The latter contains a gene encoding histone deacety-
lase 1 (HDAC1) which has been strongly implicated as the
provider of epigenetic silencing that underpins the tran-
scriptional programme of the intraerythrocytic 48 h
asexual replication cycle and which appears to be switched
off upon conversion to gametocytes [45]. Block 3 CNVs
further showed a strong positive association with another
deletion on chromosome 9, cnv9_259, which contains a
gene encoding a component of cytochrome oxidase, an
enzyme used in the energy-generating electron transport
chain in the mitochondrion. Malaria parasites increase
their dependence on mitochondrial activity upon conver-
sion to gametocytes [46, 47]. Combined, the data suggest
that cnv9_254 and cnv9_259 deletions, in conjunction
with Block 3 CNVs, are involved in up-regulation of sex-
ual stage activities.
This contrasts with Block 1 CNVs which associated
with loss of sexual function and perhaps gain in asexual
function. Block 1 contains cnv9_269, the chromosome 9
deletion causing loss of gametocyte production discussed
above, and another deletion, cnv11_355, which, as for
cnv9_269, contains a gene involved in export of proteins
to the red cell surface, Pf332 [48]. Block 1 also includes
a CNV on chromosome 2, cnv2_013, which, like cnv9_
269, is frequently found in laboratory isolates adapted to
in vitro culture. However, this CNV was amplified in
field parasites, whereas in vitro, only deleted forms are
found. cnv2_013 contains genes encoding KAHRP and
PTP1, both of which are involved in export to the red
cell surface and cytoadherence in asexual blood stage
parasites [49, 50], and LSAP2, which is associated with
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liver stage infection [51]. Other genes contained within
Block 1 amplification CNVs included the liver stage mer-
ozoite protein, PALM, the eukaryotic translation elong-
ation factor EF-G, and geranylgeranyltransferase, all of
which are highly expressed during the asexual blood or
liver stages. Thus it appears that Block 1 amplifications
are associated with functions relating to in vivo asexual
replication and survival, including cytoadherence, while
Block 1 deletions are associated with loss of sexual func-
tion, though also some components of cytoadherence.
Both of the amplification CNVs in Block 1 (cnv2_013
and cnv6_125) showed a strong negative correlation with
the CNV directly adjacent to cnv2_013, namely, cnv2_
014. cnv2_014, also an amplification, contains two genes
which are both abundantly expressed in gametocytes
and ookinetes [28]. One of these genes encodes a protein
found in the parasite surface membrane (ETRAMP2)
which is expressed in mosquito stages, including
sporozoites [52], and for which other family members
[53], but not this [54], are essential for liver stage
Fig. 4 Associations between CNVs and sexual stage function. a pairwise linkage disequilibrium between CNV alleles. Heatmap colours indicate
the strength and direction of the correlation between isolates across populations (r-value, white indicates the same CNV). Colour bars on left
indicate the type of CNV and the strength and direction of its transmission intensity related frequency clines. CNVs were clustered (top
dendrogram) by similarity in correlation profiles. CNVs with low linkage disequilibria are excluded. b Ratio of sexual to asexual stage expression
(y-axis) for individual inside the genes in (a) grouped by linkage disequilibrium block and CNV type (Amp., amplification; Del., deletion)
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development in the rodent malaria parasite, P. berghei.
This apparent antagonism between cnv2_014 and Block
1 amplifications bolsters support for our proposition that
Block 1 CNVs create loss of sexual function and con-
comitant gain in asexual function.
An unexpectedly high proportion of amp-del CNVs
were among those showing strong population-level associ-
ations (10 of all 10 amp-dels vs. 13 of 31 deletions and 12
of 58 amplifications, P < 0.001 by Fisher’s Exact test). The
amp-dels fell mainly within Blocks 2 and 3, and clustered
with amplification CNVs. We propose that amp-del CNVs
alter their copy number negatively or positively to suit the
prevailing functional needs of asexual vs. sexual parasites,
as driven by CNVs in Block 1 and Block 3.
We interpret the associations between sets of CNVs in
population prevalence as the outcome of co-selection on
reproductive vs. replicative investment which differs ac-
cording to local transmission intensity. In a parallel
study on gene expression levels, we have shown that par-
asites in low transmission areas invest more in
reproduction and less in asexual replication than para-
sites from high transmission areas [55]. We cannot say
which environmental factors wield the strongest select-
ive forces, but the most likely candidates are average in-
fection intensities (and hence in-host competition levels),
levels of host population immunity, host genetics, drug
treatment and transmission opportunities, all of which
vary widely between geographical areas and lead to
different benefit cost-ratios of reproduction and replica-
tion [4]. Alternatively, it is possible that associations
between CNV subsets are generated by an over-arching
mechanism that coordinates the spontaneous induction
of sets of functionally related CNVs. This seems less
likely, but not impossible since some strongly correlated
CNVs lie adjacent to each other on the chromosome. In
particular, CNVs on chromosome 9 were influential and
antagonistic, perhaps suggesting that they arise through
remodeling of this chromosome at the time of switching
from asexual replication to sexual reproduction.
Conclusions
The results of this study show that gene copy number
variation is common in natural populations of P. falcip-
arum parasites, consistent with previous studies. They
also provide, for the first time, evidence that CNVs in
Plasmodium provide adaptive value in the face of natural
selection pressures in the parasite’s field environment.
This evidence is based on observations of more than
expected CNVs which display transmission intensity-
related population differentiation, of strong population-
level associations between CNVs, and that these CNVs
contain genes which directly affect short-term in-host
fitness (replication) and longer term between-host fitness
(reproduction).
We interpret population differences in frequencies of
CNVs as the product of three components, namely, the
inherent trade-off between asexual replication and
reproduction in the parasite’s life cycle; the conflict
between short-term (in-host) and long-term (between-
host) fitness; and the different benefit-cost ratios of these
fitness components in different transmission environ-
ments. For example, in the case of cnv9_269, the sacri-
fice of gametocyte production incurs little cost in
environments with few mosquitoes, thus allowing short-
term selection that favours asexual replication to domin-
ate over longer term selection for transmission to new
hosts. Our finding that CNVs cluster according to repro-
ductive vs. replicative functions, and that there are
antagonistic associations among deletions that are ex-
pected to nullify these functions, suggests that the short-
term selection argument generalizes to other CNVs too,
generating co-selected suites of CNVs specialized for
these two highly differentiated life stages.
It is difficult to explain how CNVs that cause loss of
function are maintained in the general population in the
field. We have proposed that this could be achieved
through maintenance of genomic fragility at CNV loci
that would allow ‘bet-hedging’ within an infection.
Under this strategy, the parasite would divide its asexu-
ally replicating lineages into mutant and non-mutant
types, thereby allowing maintenance of both asexual rep-
lication and reproduction and thus carryover to the next
generation. Splitting of function in this way is akin to
somatic differentiation of tissues in multi-cellular organ-
isms which allows a balance between growth and
reproduction to be achieved in order to maximize life-
time fitness. However, in Plasmodium, it is fitness of the
individual parasite, not the population of parasites
within the infection, which is rewarded. Although kin se-
lection has been proposed to play a role in the evolution
of life history traits in Plasmodium [56], there are few
empirical studies to test this. Moreover, it is clear that
competition between different genotypes occupying the
same host is a strong determinant of the fitness of indi-
vidual parasite genotypes [57]. This leads us to conclude
that CNVs that abrogate sexual function are likely to be
the outcome of short-term selection only in the limited
situation where infections are clonal and when oppor-
tunities for transmission are extremely low. By contrast,
we interpret the finding of CNVs associated with en-
hanced reproductive function as the outcome of se-
lection for between-host transmission when there are
regular transmission opportunities and the benefits of
switching to reproduction outweigh the costs of re-
duced asexual replication [41, 58].
This study has some limitations. First, although high
stringency was applied in defining CNVs (this by apply-
ing high thresholds for significance, filtering out probes
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targeting highly polymorphic genes, probes with known
SNPs within the probe sequences, poorly hybridizing
probes and low frequency CNVs), it cannot be ruled out
that unaccounted for DNA sequence variation in the
field isolates caused poor probe hybridization thereby
leading to false CNVs. Studies of probe hybridization as
a function of number of base pair differences between
probe and target suggest that 7 out of the 70 bases
would have to be different in order to cause non-
hybridisation [59]. Second, CNVs in the reference para-
site (P4) genome may have led to an over- or underesti-
mation of CNV prevalence. To account for this, we
reported CNV frequencies with respect to the allele with
the minor frequency. Third, microarray data provide low
resolution of CNV breakpoints, leading to potentially in-
correct start and endpoints of a CNV and hence lower
accuracy of detection. Finally, choice of reference mater-
ial, statistical methods, power, significance thresholds,
platforms and technologies all differ widely between
studies, thus eroding comparability across studies, espe-
cially for CNVs not validated through other methods.
Although the chromosome 9 deletion is well validated
by a variety of detection technologies, including the
array used here [18], it is important that the novel find-
ing in this study of its presence in field populations is
tested through independent investigations.
Overall, this study shows that CNVs contribute sub-
stantially to levels of standing genetic variation in P. fal-
ciparum in natural populations and provides multiple
lines of evidence that some of these CNVs are adaptive
in the face of geographic and temporal variation in the
parasite’s transmission environment. Further investiga-
tion of CNV genes in relation to gene expression levels,
of their broader phenotypes, and of the specific selection
pressures that mould their population frequencies will
provide new leads on molecular mechanisms that allow
malaria parasites to survive and adapt, ultimately leading
to new ways to control malaria.
Methods
Sample population
Parasites were obtained by venesection of < 3 ml of
blood from patients diagnosed with P. falciparum mal-
aria by microscopy that attended healthcare facilities
with symptoms. They were recruited from three areas in
Eastern Africa, namely, eastern Sudan (Gedaref, Kassab,
Medani, recruited in October 2007), western Kenya (Ki-
sumu, recruited in April–May 2008) and coastal Kenya
(Kilifi, recruited in April–May 2010). These areas have
maintained low, high and moderate malaria transmission
intensities, respectively, over a long period [55]. In Kilifi,
archived parasite samples collected from patients re-
cruited from the hospital 15 years previously (1994 to
1996), when transmission intensity was much higher
than in 2010 [60], were also analysed: this gave a further
contrast of medium-high (“Kilifi-pre”) vs. medium-low
(“Kilifi-post”) transmission populations.
Sample processing
After centrifugation, the plasma and buffy coat were re-
moved in order to minimize contaminating human host
DNA. For samples from Kilifi, 30–200 μl of parasite-
infected red blood cells (iRBCs) were stored frozen then
thawed on ice and saponified in order to remove intact
parasites from RBCs. From this lysate, genomic DNA
was extracted using the phenol chloroform method. For
samples from Sudan and Kisumu, DNA was extracted
from 100 μl of iRBCs, which had been stored frozen,
using the automated ABI PRISM 6100 Nucleic Acid Pre-
pStation (Applied Biosystems). The number of parasite
clones in an isolate was determined by genotyping P. fal-
ciparum merozoite surface antigen 2 (msp2) gene [61].
Comparative genomic hybridization
The microarray used for this study consisted of 70mer
oligonucleotides (probes) spotted on a glass slide [59].
The probes on the array were designed using the avail-
able complete P. falciparum genome sequence of 3D7
parasite line [62] targeting conserved regions of approxi-
mately 5400 genes with an average of two probes per
gene [59]. This array has been previously validated for
detection of CNVs [18, 63]. Comparative genomic
hybridization (CGH) was performed on 183 samples
using as a reference the laboratory culture-adapted line,
P4, that originated from a malaria patient at the Kilifi
District Hospital [18]. To increase the amount of DNA
available for hybridization to the array, whole genome
amplification using random nonamers was performed
[64]. Samples were randomized across population groups
during amplification and hybridization experiments to
avoid batch-of-processing bias. Cyanine fluorescent dyes
(Cy3 for reference DNA and Cy5 for test DNA) were
used for DNA labelling using the Klenow fragment. PCR
amplification was terminated after 19 cycles (during the
linear phase) in order to preserve the starting values of
relative DNA abundance per gene. Competitive
hybridization of each of the test samples against the ref-
erence was performed on a MAUI 12-bay hybridization
station (BioMicro Systems). Microarray slides were
scanned and analysed using GenePix 4000B microarray
scanner and its software (version 4.0).
Pre-processing of microarray data
Analysis of the microarray data was performed using the
limma package in R [65]. First, poor quality spots (less
than 6 pixels, or with size that greatly differed from that
in the GAL file) were filtered out of the data. Second,
data were normalised for spot intensity within arrays
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using the ‘normexp’ [66] and ‘robustspline’ [67] methods.
Third, data were normalized for between-array variation
using the “quantile” method. Data from genes encoding
the variant antigen gene families of var., rifin and stevor,
and other multi-copy or highly variable genes, ribosomal
RNAs and transfer RNAs were excluded from further
analyses.
Detection of gene copy number variation using R-GADA
Genomic regions that varied in copy number were iden-
tified using the Genome Alteration Detection Analysis
(GADA) program in R [68]. The GADA method identi-
fies contiguous segments in the genome in which log2
intensity differs from that of flanking genes. ‘Significant’
segments were declared based on a t-statistic calculated
from the mean and variance of all the segments (‘T’)
after applying segmentation analysis with segment length
being controlled by the parameter aα. Here, we used the
recommended thresholds for high sensitivity but also
high false discovery rate of T = 3.5 and aα [69]. To re-
duce false discovery rates, we filtered out segments with
less than two microarray probes within the segment and
an absolute amplitude of log2 ratio of < 1 (< 2-fold
change in gene copy number). Since GADA CNV break-
point predictions are not precise, and breakpoints also
can vary between samples for biological reasons, loca-
tions of the start and end points of segments varied be-
tween samples. Therefore, segments with overlapping
locations across samples and of similar types (i.e., ampli-
fication vs. deletion) were merged into a single CNV:
this further protected against false discoveries. Finally,
CNVs found in less than 4 out of 183 isolates were ex-
cluded from the final list of CNVs used in subsequent
analyses.
Systematic effects of experimental, host and gene factors
Population prevalence of each CNV – where population
is defined as number of hosts as compared with number
of distinct parasite genomes - was analysed as a binary
variable (present vs. absent) for the systematic effects of
population, multiplicity of infection (MOI), haemoglo-
bin, age of participant, parasitaemia, experimental batch
and parasite isolate using mixed effects logistic regres-
sion models in the lme4 package in R [70]. All effects
were fitted as fixed-level factors with the exception of
batch and isolate which were fitted as random effects,
the latter to allow for repeated measures on the same
parasite material. The same model was fitted to data
from all CNVs simultaneously but with further inclusion
of CNV identifier as a random effect: this was to test for
generalized bias from the above factors in overall CNV
detectability while accounting for repeated measures on
the same CNV. Significance of fixed effects was assessed
by analysis-of-variance F-tests.
Prevalence of CNVs in the genome was analysed for
the systematic effects of the following gene properties:
SNP density (obtained from PlasmoDB), ratio of expres-
sion during the sexual vs. asexual stages of the life cycle
(obtained from [71]), and the stage during the 48 h asex-
ual replication cycle at which it was maximally expressed
(based on data in [55]). A logistic regression model was
fitted to the binary variable of whether the gene was a
member of a CNV or not fitting fixed effects for fixed-
level factors for the gene property traits above. Analyses
were performed separately for CNVs that were deletions
vs. amplifications: CNVs exhibiting both of these were
ignored. Significance was assessed by analysis-of-
deviance likelihood ratio tests. For all models, least-
squares means were calculated for each level of the fixed
effects using the lsmeans package in R [72].
Functional enrichment
Enrichment for function among genes identified to be
copy number variable was assessed by hypergeometric
test for over-representation of CNVs among sets of func-
tionally related genes, implemented by using the ‘phyper’
function in the stats package in R [73] and corrected for
multiple testing using the Benjamini-Hochberg method
[74]. Gene sets were constructed from the Malaria Para-
site Metabolic Pathways database [75] and further cate-
gorized into higher level functional groupings as
described in [55].
Testing for evidence of population-level adaptation
To test for evidence of CNV-related population level
adaptation in general, Weir and Cockerham F-statistics
(FST) for levels of between-to-within population vari-
ation in allele frequencies were calculated for each CNV
using hierfstat as implemented in R [76]. CNVs with un-
usually high or low values, and thus potential targets of
directional and diversifying selection, respectively, were
identified by comparing them to the distribution of FST
values for all CNVs. To determine whether these popula-
tion differences were related to transmission intensity in
the population, a fixed effects logistic regression model
was fitted to prevalence data for each CNV with popula-
tion fitted as a linear covariate representing the popula-
tions’ ranks in transmission intensity, i.e., 1 to 4 for
Sudan, Kilifi-post, Kilifi-pre and Kisumu respectively.
This model was fitted to data on all CNVs simultan-
eously, with CNV fitted as a fixed effect and the popula-
tion covariate fitted within CNV. The standardized
regression slopes (z-score) for each CNV, which repre-
sent the cline in CNV frequency across the transmission
intensity gradient, were compared to a null distribution
of slopes constructed by fitting the same model to 1000
permutations of the data in which population member-
ship of each parasite isolate had been randomly
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reassigned. Unadjusted P-values for regression slopes
were based on t-tests using the error variance from all
CNVs combined. To allow for multiple testing, P-values
were adjusted to reflect a false discovery rate using the
Benjamini-Hochberg method [74].To test whether the
observed distribution of slopes for all the CNVs differed
from that expected by chance, a global test statistic,
namely, the sum of the absolute z-scores, was computed
for the observed data and compared to the distribution
of this statistic from the permuted data. CNVs with sig-
nificant clines (adjusted P < 0.05) or FST values > 0.3 for
at least one of their pairwise population values were de-
fined as ‘adaptive’.
Linkage disequilibrium
To test for population level associations between CNVs,
linkage disequilibria between all pairwise combinations
of CNVs were calculated using the pegas package in R
[77]. Pearson correlations were computed between fre-
quencies of the CNVs’ minor alleles (r-values). CNVs
with both amplification and deletion alleles were treated
separately. Results were visualized as a heatmap using
the pheatmap package in R.
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